←
Alerje1,180 posts
Alerje avatar

Alerje

@alerje

We believe that food allergies should not get in the way of making every moment in our lives count. #makeeverymomentcount🧡

◷ Joined August 2015▧ 291 Photos and videos
Medical Economics avatar
⟳ Alerje retweeted
Medical Economics@MedEconomics·4 Dec 2025

Sempresto acquires Alerje’s smartphone-mounted auto-injector platform — strengthening its lead in mobile drug delivery tech. Alerje now shifts to AI-powered food allergy tools. Full story: hubs.li/Q03WWNf60 #MedicalEconomics #MedTech #DigitalHealth #SmartphoneHealth

Engineering + Research + Medicine🔍🔬🌱 avatar
⟳ Alerje retweeted
Engineering + Research + Medicine🔍🔬🌱@Engineer_Health·4 Dec 2025

Amazing 👏🏼 Bravo to @alerje Sempresto Acquires Alerje’s Autoinjector Platform to Accelerate Commercialization of Smartphone Integrated Rescue Medications - businesswire.com/news/home/2…

CTIP avatar
⟳ Alerje retweeted
CTIP@ctipmedtech·4 Dec 2025

We're proud to support @alerje, one of our portfolio companies, as they enter a new chapter focused on improving outcomes for food allergy families. Excited to see what's next for them!

Alerje@alerje4 Dec 2025

We've completed the sale of the OmniJect device to SemPresto! This honors the work behind the device and places it with a world class team to take it forward. Our mission remains the same, focusing on collaborative, connected food allergy care! businesswire.com/news/home/2…

Alerje avatar
Alerje@alerje·4 Dec 2025

We've completed the sale of the OmniJect device to SemPresto! This honors the work behind the device and places it with a world class team to take it forward. Our mission remains the same, focusing on collaborative, connected food allergy care! businesswire.com/news/home/2…

Alerje avatar
Alerje@alerje·10 Nov 2025

We had a great time at this year’s @ACAAI, connecting with new and familiar faces across the allergy and immunology community. Always inspiring to hear about the latest innovations and see how aligned we all are. Excited for what’s ahead! #ACAAI2025

Post attachmentPost attachment
Alerje avatar
Alerje@alerje·6 Aug 2025

Alerje has officially received its 14th issued patent, our 1st software based IP! US 12380979, covers our integrated system for food allergy immunotherapy monitoring combining connected devices, physician dashboards, and personalized treatments 🥜🧪📱

Post attachment
Alerje avatar
Alerje@alerje·23 Jun 2025

We’re excited to share that Alerje has been awarded a ~$200K @NSF TECP supplemental grant! This support fuels our mission to transform allergy care, and reflects the power of focus, aligned partners, & long term vision. Grateful & energized for what’s ahead! 🧡 #NSF #TECP

Post attachment
Alerje avatar
Alerje@alerje·17 Mar 2025

As we continues to advance our food allergy care platform, we're excited to announce two key additions to our leadership team! They enhance our clinical expertise and regulatory capabilities at a pivotal moment in our company's growth journey. 🚀 linkedin.com/pulse/strategic…

Post attachment
Alerje avatar
Alerje@alerje·19 Feb 2025

We’re excited to share that Alerje has reached another global milestone! 🌍 Our epinephrine auto-injector phone case just earned a patent in Japan 🇯🇵, expanding access to fast, reliable emergency care. As food allergies rise, we’re committed to supporting those who need it most.

Post attachment
Alerje avatar
Alerje@alerje·4 Feb 2025

Innovation is a team effort! Big shoutout to our engineers & designers for helping secure another U.S. patent for Alerje. Our epinephrine auto-injector phone case makes emergency allergy care more accessible than ever. Onward! 🧡🚀

Post attachmentPost attachment